Mynd Life Sciences
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
R&D project on psilocybin’s benefits in treating diseases of the brain VANCOUVER, BC, Nov. 30, 2021 /CNW/ – MYND Life Sciences...
Mynd Life Sciences
- Nov 30, 2021
MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation
R&D project on psilocybin’s benefits in treating diseases of the brain VANCOUVER, BC, Nov. 30, 2021 /CNW/ – MYND Life Sciences Inc. ...
Mynd Life Sciences
- Nov 22, 2021
MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test
MYND Diagnostics will be initiating a clinical validation study on the use of its proprietary biomarker testing in Multiple Sclerosis...